Cross-Reactive Bactericidal Antimeningococcal Antibodies

The threat from invasive meningococcal disease (IMD) remains a serious source of concern despite the licensure and availability of vaccines. A limitation of current serogroup B vaccines is the breadth of coverage afforded, resulting from the capacity for extensive variation of the meningococcus and its huge potential for the generation of further diversity.

Publication

Report Infringement

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Article

Teaching university subjects online, changing technology and pedagogical practice

Next Article

A Different Kind of Teacher for a Different Kind of School

×
As a Guest, you have insight(s) remaining for this month. Create a free account to view 300 more annually.
Related Posts
error:

Add the Faculti Web App to your Mobile or Desktop homescreen

Install
×